Non-high density lipoprotein cholesterol versus low density lipoprotein cholesterol as a discriminating factor for myocardial infarction

BMC Research Notes

Volumn 5, Issue , 2012, Pages

  Sigdel, Manoj ^a   Yadav, Binod Kumar ^b   Gyawali, Prajwal ^c   Regmi, Prashant ^d   Baral, Sushil ^e   Regmi, Shyam Raj ^b   Jha, Bharat ^f  

^a MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

^b Shahid Gangalal National Heart Centre   (Nepal)

^c CHARLES STURT UNIVERSITY   (Australia)

^d Yeti Health Science Academy   (Nepal)

^e NEPAL MEDICAL COLLEGE   (Nepal)

^f TRIBHUVAN UNIVERSITY   (Nepal)

Author keywords

Dyslipidemia; LDL cholesterol; Myocardial infarction; non HDL cholesterol

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD; CASE CONTROL STUDY; CROSS-SECTIONAL STUDY; DIET RESTRICTION; FEMALE; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; RECEIVER OPERATING CHARACTERISTIC; REFERENCE VALUE; RISK FACTOR; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; CROSS-SECTIONAL STUDIES; FASTING; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REFERENCE VALUES; RISK FACTORS; ROC CURVE; TRIGLYCERIDES;

EID: 84869028970     PISSN: None     EISSN: 17560500     Source Type: Journal    
DOI: 10.1186/1756-0500-5-640     Document Type: Article

References (24)

1. Acute Myocardial Infarction in a Southeast Indian Population: Comparison of Traditional and Novel Cardiovascular Risk Factors. Bitla AR, Pallavi M, Vanaja V, Suchitra MM, Reddy VS, Reddy EP, Rao PVLNS, Res J Med Med Sci 2009 4 2 202 206
2. Is there a need for novel cardiovascular risk factors ? Arnold VE, Nephrol Dial Transplant 2004 19 761 765 10.1093/ndt/gfh111 15031325
3. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Expert Panel on Detection Evaluation, and Treatment of High Blood Cholesterol in Adults, JAMA 2001 285 2486 2497 10.1001/jama.285.19.2486 11368702
4. Non-high-density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality. Cui Y, Blumenthal RS, Flaws JA, Whiteman MK, Langenberg P, Bachorik PS, Bush TL, Arch Intern Med 2001 161 1413 1419 10.1001/archinte.161.11.1413 11386890
5. Non-high-density lipoprotein cholesterol versus low-density lipoprotein cholesterol as a risk factor for a first nonfatal myocardial infarction. Farwell WR, Sesso HD, Buring JE, Gaziano JM, Am J Cardiol 2005 96 1129 1134 10.1016/j.amjcard.2005.06.044 16214451
6. Non-high density lipoprotein and very-low-density lipoprotein cholesterol and their risk predictive values in coronary heart disease. Liu J, Sempos CT, Donahue RP, Dorn J, Trevisan M, Grundy SM, Am J Cardiol 2006 98 1363 1368 10.1016/j.amjcard.2006.06.032 17134630
7. Clinical utility of different lipid measures for prediction of coronary heart disease in men and women. Ingelsson E, Schaefer EJ, Contois JH, McNamara JR, Sullivan L, Keyes MJ, Pencina MJ, Schoonmaker C, Wilson PWF, D'Agostino RB, Vasan RS, JAMA 2007 298 776 785 10.1001/jama.298.7.776 17699011
8. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): final report. The Expert Panel, Circulation 2002 106 3143 3421 12485966
9. High-density lipoprotein: the clinical implications of recent studies. Gordon DH, Rifkind BM, N Engl J Med 1989 321 1311 1316 10.1056/ NEJM198911093211907 2677733
10. HDL1, HDL2, and HDL3 subfractions, and the risk of acute myocardial infarction. A prospective population study in eastern Finnish men. Salonen JT, Salonen R, Seppänen K, Rauramaa R, Tuomilehto J, Circulation 1991 84 129 139 10.1161/01.CIR.84.1.129 2060089
11. High density lipoprotein as a protective factor against coronary heart disease. The Framingham study. Gordon T, Castelli WP, Hjortland MC, Kannel WB, Dawber TR, Am J Med 1997 62 5 707 714
12. CETP and atherosclerosis. Barter P, Arterioscler Thromb Vasc Biol 2000 20 2029 2031 10.1161/01.ATV.20.9.2029 10978244
13. HDL and apolipoprotein A-I protect erythrocytes against the generation of procoagulant activity. Epand RM, Stafford A, Leon B, Lock PE, Tytler EM, Segrest JP, Anantharamaiah GM, Arterioscler Thromb Vasc Biol 1994 14 11 1775 1783 10.1161/01.ATV.14.11.1775
14. Activation of fibrinolysis by apolipoproteins of high density lipoproteins in man. Saku K, Ahmad M, Glas-Greenwalt P, Kashyap ML, Thromb Res 1985 39 1 8 10.1016/0049-3848(85)90116-1 4035643
15. Antioxidant properties of HDL in transgenic mice overexpressing human apolipoprotein A-II. Boisfer E, Stengel D, Pastier D, Laplaud PM, Dousset N, Ninio E, Kalopissis AD, J Lipid Res 2002 43 5 732 741 11971944
16. Adherence of mononuclear cells to endothelium in vitro is increased in patients with NIDDM. Carantoni M, Abbasi F, Chu L, Chen YDI, Reaven GM, Taso PS, Varasteh B, Cooke JP, Diabetes Care 1997 20 1462 1465 10.2337/diacare.20.9.1462 9283798
17. Very low density lipoproteins promote triglyceride accumulation in macrophages. Bates SR, Murphy PL, Feng Z, Kanazawa T, Getz GS, Arteriosclerosis 1984 4 103 114 10.1161/01.ATV.4.2.103 6704048
18. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunoabsorption from human atherosclerotic plaque. Rapp JH, Lespine A, Hamilton RL, Colyvas N, Chaumeton AH, Tweede-Hardmann J, Kotite L, Kunitake ST, Havel RJ, Kane JP, Arterioscler Thromb Vasc Biol 1994 14 1767 1774 10.1161/01.ATV.14.11.1767
19. Triglyceride-rich lipoproteins inhibit cholesterol efflux to apolipoprotein (apo) A1 from human macrophage foam cells. Palmer AM, Murphy N, Graham A, Atherosclerosis 2004 173 27 38 10.1016/j.atherosclerosis.2003.12.001 15177121
20. Triglyceride and cholesterol rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Hodis HN, Mack WJ, Azen SP, Alaupovic P, Pogoda JM, LaBree L, Hemphill LC, Kramsch DM, Blankenhorn DH, Circulation 1994 90 42 49 10.1161/01.CIR.90.1.42 8026027
21. Low-density lipoprotein, non-high-density lipoprotein, and apolipoprotein B as targets of lipid-lowering therapy. Grundy SM, Circulation 2002 106 2526 2529 10.1161/01.CIR.0000038419.53000.D6 12427645
22. Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (≤ 40 years of age). Goliasch G, Oravec S, Blessberger H, Dostal E, Hoke M, Wojta J, Schillinger M, Huber K, Maurer G, Wiesbauer, Eur J Clin Invest 2012 42 6 631 636 10.1111/j.1365-2362. 2011.02629.x 22150092
23. Non-HDL Cholesterol, Apolipoproteins A-I and B100, Standard Lipid Measures, Lipid Ratios, and CRP as Risk Factors for Cardiovascular Disease in Women. Ridker PM, Rifai N, Cook NR, Bradwin G, Buring JE, JAMA 2005 294 3 326 333 10.1001/jama.294.3.326 16030277
24. Rationale for use of non-high-density lipoprotein cholesterol rather than low-density lipoprotein cholesterol as a tool for lipoprotein cholesterol screening and assessment of risk and therapy. Frost PH, Havel RJ, Am J Cardiol 1998 81 4A 26B 31B 9526810